PHI1.F - Koninklijke Philips N.V.

Frankfurt - Frankfurt Prix différé. Devise en EUR

Koninklijke Philips N.V.

Philips Center
Amstelplein 2
Amsterdam 1096 BC
31 20 597 7777

Secteur d’activitéMedical Devices
Employés à temps plein73 712

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Mr. Roy JakobsPres, CEO & Chairman of Management1,28MS.O.1974
Dr. Paulus A. Stoffels M.D., Ph.D.Independent Vice Chairman of Supervisory Board & Sec.177,27kS.O.1962
Mr. Abhijit BhattacharyaExec. VP, CFO & Member of the Board of Management1,13M485,44k1961
Mr. Marnix J. van GinnekenExec. VP, Chief ESG, Legal Officer & Member of the Board of Management831,35k244,75k1973
Mr. Willem AppeloExec. VP & COOS.O.S.O.1965
Mr. Leandro MazzoniHead of Investor RelationsS.O.S.O.S.O.
Ms. Daniela SeabrookExec. VP & Chief HR OfficerS.O.S.O.1973
Mr. Sean CarneyChief Design OfficerS.O.S.O.S.O.
Mr. Andy HoExec. VP & Chief Market Leader of Philips Greater ChinaS.O.S.O.1961
Jan KimpenChief Medical OfficerS.O.S.O.1958
Les montants ont été établis en date du 31 décembre 2022 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en EUR.


Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. The company provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease; proprietary software to enable diagnostics and intervention; and enterprise diagnostic informatics products and services. It also offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. In addition, the company provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. It has strategic partnership agreements with TriHealth, Prisma Health, and the University Health System of San Antonio to help the health system standardize patient monitoring, drive interoperability, and lay the foundation for enterprise-wide platform; and Oulu University Hospital to deliver advanced image-guided therapy solutions. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Koninklijke Philips N.V. en date du 1 juin 2023 est 3. Les scores principaux sont Audit : 1; Société : 1; Droits des actionnaires : 5; Compensation : 6.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.